Delivery Order SPE2DB22D3501-SPE2DB25FVL89
Award Date
4/29/25
Potential Completion Date
4/30/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,063.41 for the supply of REMIFENTANIL 1 MG VIALS. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 22, 2024. The contract is a Firm Fixed Price arrangement, and no set-aside designation was used. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,426.20, is for the delivery of 4,567,884,944 vials of the drug Remifentanil 2 mg. The contract is a firm fixed price Delivery Order, with an ultimate completion date of April 14, 2025. The contract was not set aside for any specific socioeconomic group. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,667.20 firm fixed-price delivery order is for the supply of 1 mg vials of the medication Remifentanil. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of REMIFENTANIL 1 MG VIALS. The delivery order contract, valued at $5,149.43, has a firm fixed price and is set to expire on October 22, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth...
This federal contract award, valued at $5,288.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides for the delivery of 1 mg vials of the pharmaceutical drug Remifentanil to support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,374.40 firm fixed-price delivery order is for the supply of 2 mg vials of the drug remifentanil, with a period of performance through November 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $12,102.16 and is for the delivery of 2 mg vials of the medication Remifentanil. The contract is a Firm Fixed Price Delivery Order with a completion date of May 16, 2024. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant Indefinite...
This contract award, SPE2DB22D2206|SPE2DB24FEG06, is a delivery order valued at $2,442.40 for the supply of 1 mg vials of the pharmaceutical drug remifentanil. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract does not have a set-aside designation, indicating it was open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,917.75, is for the delivery of REMIFENTANIL 2 MG VIALS, a specialty medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,190.42, is for the delivery of Remifentanil 1 mg vials, a specialty medication used for pain management. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...